Specialty Pharmacy

Baricitinib shows statistically significant improvements in quality of life and physical function.

Top articles of the day from across the health care landscape.

Top articles of the week on Specialty Pharmacy Times.

Elderly African American multiple myeloma patients had lower rates of access to autologous stem cell transplant.

Treatment nearly doubled the risk of severe hypoglycemia that required medical attention in patients with type 2 diabetes.

Increased fat deposits consistent with obesity experienced disease relapse.

An increasing number of patients with HIV are 50 or older, which comes with new challenges for health care providers.

FDA seeks to halt the sale and distribution of counterfeit or illegal drugs online.

Approximately half of all cancer deaths may be preventable by behavior modifications.

APR-246 was seen to successfully target mutated p53 genes in patients with cancer.

Acute infection screening program for HIV shows promise.

Breast cancer treatments that are similar in effectiveness are priced very differently, researchers discovered.

High rates of foster and Medicaid-insured children are receiving antipsychotics, but providers are not following the recommended guidelines.

Gut bacteria found to influence the activity of cells in the brain that control inflammation and neurodegeneration.

D-Methadone was seen to have a superior effect on mobility than ketamine in postherpetic neuralgia.

Radon already associated with lung cancer development.

Combination imaging found to reduce recall rate in patients with breast cancer.

Top news of the day from across the health care landscape.

Informed choices of therapy regimens could save up to $1 billion annually in cancer drug spending.

Selinexor combined with liposomal doxorubicin and dexamethasone shows promise.

Study hopes to overcome significant challenges in producing an HIV vaccine.

Top news of the day from across the health care landscape.

Metformin found to improve survival in breast cancer and shows promise in endometrial hyperplasia.

Progression-free survival was seen in 16 patients treated with a combination of nivolumab and ipilimumab.

Study finds social media content can be analyzed for use in MS outcomes research.

Study of clinical development success rates finds phase 2 trials are less successful than any other R&D phase.

Cost and access burdens among individuals at-risk for cancer improved through phone counseling.

Patients with mutations in the gene NR1H3 have a 70% chance of developing a progressive form of MS.